Publication | Open Access
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
67
Citations
43
References
2017
Year
Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyTherapeutic EfficacyAdult T-cell Leukemia-lymphomaImmunotherapyMedicineCell BiologyTumor MicroenvironmentBcl-2 Inhibition
| Year | Citations | |
|---|---|---|
Page 1
Page 1